A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-γ and interleukin-10 in natural killer cells of healthy blood donors

Journal of Infectious Diseases

Volumn 182, Issue 2, 2000, Pages 570-578

  Maasho, K ^a   Satti, I ^a,b   Nylen, S ^a   Guzman, G ^a   Koning, F ^c   Akuffo, H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN KINASE C;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LEISHMANIASIS; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, PROTOZOAN; BLOOD DONORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; KILLER CELLS, NATURAL; LEISHMANIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; PHENOTYPE; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE;

EID: 0033844492     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315725     Document Type: Article

References (25)

1. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
2. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis
3. Identification of antigens recognized by T cells in human leishmaniasis: Analysis of T-cell clones by immunoblotting
4. + T cells associated with cure of human cutaneous leishmaniasis
5. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans
6. Natural and acquired resistance to Leishmania: Cellular activation of Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of NK cells
7. Indication of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity
8. Resistance to Leishmania major induced by tolerance to a single antigen
9. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major
10. Expression cloning of a protective Leishmania antigen
11. Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotes
12. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production
13. Antibody dependent cellular cytotoxicity mediated by HLA-class II specific monoclonal antibodies
14. A mouse monoclonal antibody detecting a DR-related MT2-like specificity: Serology and biochemistry
15. Separation of lymphocytes from blood and bone marrow
16. Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease
17. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies
18. Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cells
19. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites
20. Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for IL-10 while those from localized leishmaniasis patients induce IFN-γ
21. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12
22. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells
23. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T-lymphocytes
24. Natural killer cell clones can efficiently process and present protein antigens
25. Interaction of natural killer cells with MHC class II: Reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A